Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsia

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Zuniga, Felipe A ^a   Ormazabal, Valeska ^b   Gutierrez, Nicolas ^a   Aguilera, Valeria ^a   Radojkovic, Claudia ^a   Veas, Carlos ^a   Escudero, Carlos ^c   Lamperti, Liliana ^a   Aguayo, Claudio ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSIDAD CATÓLICA DE LA SANTÍSIMA CONCEPCIÓN   (Chile)

^c UNIVERSIDAD DEL BÍO BÍO   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; REACTIVE OXYGEN METABOLITE; LECTIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

APOPTOSIS; CELL MIGRATION; ENDOTHELIAL DYSFUNCTION; FETOPLACENTAL UNIT; HUMAN; PATHOPHYSIOLOGY; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANT WOMAN; REVIEW; ROLE PLAYING; SYNCYTIOTROPHOBLAST; FEMALE; FETUS; METABOLISM; PLACENTA; PREGNANCY; VASCULARIZATION;

FEMALE; FETUS; HUMANS; LECTINS; LIPOPROTEINS, LDL; NITRIC OXIDE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 84904824052     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/353616     Document Type: Review

References (147)

1. Michiels C., Endothelial cell functions. Journal of Cellular Physiology 2003 196 3 430 443 2-s2.0-0041767435 10.1002/jcp.10333 (Pubitemid 36927738)
2. Messner B., Demougeot C., Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2014 34 509 515 10.1161/ATVBAHA.113.300156
3. Totoson P., Maguin-Gate K., Prati C., Wendling D., Demougeot C., Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies. Arthritis Research & Therapy 2014 16 1, article R22
4. Gutierrez E., Flammer A. J., Lerman L. O., Elizaga J., Lerman A., Fernandez-Aviles F., Endothelial dysfunction over the course of coronary artery disease. European Heart Journal 2013 34 41 3175 3181 10.1093/eurheartj/eht351
5. Roberts A. C., Porter K. E., Cellular and molecular mechanisms of endothelial dysfunction in diabetes. Diabetes and Vascular Disease 2013 10 472 482 10.1177/1479164113500680
6. Brennan L. J., Morton J. S., Davidge S. T., Vascular dysfunction in preeclampsia. Microcirculation 2014 21 1 4 14 10.1111/micc.12079
7. Arnal J.-F., Dinh-Xuan A.-T., Pueyo M., Darblade B., Rami J., Endothelium-derived nitric oxide and vascular physiology and pathology. Cellular and Molecular Life Sciences 1999 55 8-9 1078 1087 2-s2.0-0032777665 (Pubitemid 29361074)
8. Yetik-Anacak G., Catravas J. D., Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vascular Pharmacology 2006 45 5 268 276 2-s2.0-33751104760 10.1016/j.vph.2006.08.002 (Pubitemid 44765289)
9. Fleming I., Busse R., Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2003 284 1 R1 R12 2-s2.0-0037216768 (Pubitemid 36008649)
10. Tousoulis D., Kampoli A. M., Papageorgiou C., Stefanadis C., The role of nitric oxide on endothelial function. Current Vascular Pharmacology 2012 10 1 4 18 2-s2.0-84857129673 10.2174/157016112798829760
11. Ignarro L. J., Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. Journal of Physiology and Pharmacology 2002 53 4 I 503 514 2-s2.0-0036912721 (Pubitemid 36014797)
12. San Martín R., Sobrevia L., Gestational diabetes and the adenosine/L-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium. Placenta 2006 27 1 1 10 2-s2.0-27944492352 10.1016/j.placenta.2005. 01.011 (Pubitemid 41662874)
13. Moncada S., Higgs E. A., Nitric oxide and the vascular endothelium. Handbook of Experimental Pharmacology 2006 176 213 254 2-s2.0-34247093334
14. Tousoulis D., Briasoulis A., Papageorgiou N., Tsioufis C., Tsiamis E., Toutouzas K., Stefanadis C., Oxidative stress and endothelial function: therapeutic interventions. Recent Patents on Cardiovascular Drug Discovery 2011 6 2 103 114 2-s2.0-79959348307 10.2174/157489011795933819
15. Myatt L., Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 2010 31 S66 S69 2-s2.0-76749110706 10.1016/j.placenta.2009.12.021
16. Sarti P., Arese M., Forte E., Giuffrè A., Mastronicola D., Mitochondria and nitric oxide: chemistry and pathophysiology. Advances in Experimental Medicine and Biology 2012 942 75 92 2-s2.0-84859917863 10.1007/978-94-007-2869-1-4
17. Hogg N., The biochemistry and physiology of S-nitrosothiols. Annual Review of Pharmacology and Toxicology 2002 42 585 600 2-s2.0-0036174890 10.1146/annurev.pharmtox.42.092501.104328 (Pubitemid 34160536)
18. Wang H., Wang A. X., Aylor K., Barrett E. J., Nitric oxide directly promotes vascular endothelial insulin transport. Diabetes 2013 62 12 4030 4042 10.2337/db13-0627
19. Sawamura T., Kume N., Aoyama T., Moriwaki H., Hoshikawa H., Aiba Y., Tanaka T., Miwa S., Katsura Y., Kita T., Masaki T., An endothelial receptor for oxidized low-density lipoprotein. Nature 1997 386 6620 73 77 2-s2.0-0030941113 10.1038/386073a0 (Pubitemid 27130922)
20. Chen M., Masaki T., Sawamura T., LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacology and Therapeutics 2002 95 1 89 100 2-s2.0-0035993485 10.1016/S0163-7258(02)00236-X
21. Honjo M., Nakamura K., Yamashiro K., Kiryu J., Tanihara H., McEvoy L. M., Honda Y., Butcher E. C., Masaki T., Sawamura T., Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proceedings of the National Academy of Sciences of the United States of America 2003 100 3 1274 1279 2-s2.0-0037417975 10.1073/pnas.0337528100 (Pubitemid 36183992)
22. Dunn S., Vohra R. S., Murphy J. E., Homer-Vanniasinkam S., Walker J. H., Ponnambalam S., The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochemical Journal 2008 409 2 349 355 2-s2.0-38749118269 10.1042/BJ20071196 (Pubitemid 351184953)
23. Mitra S., Goyal T., Mehta J. L., Oxidized LDL, LOX-1 and atherosclerosis. Cardiovascular Drugs and Therapy 2011 25 5 419 429 2-s2.0-83055194366 10.1007/s10557-011-6341-5
24. Cominacini L., Rigoni A., Pasini A. F., Garbin U., Davoli A., Campagnola M., Pastorino A. M., Lo Cascio V., Sawamura T., The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. The Journal of Biological Chemistry 2001 276 17 13750 13755 2-s2.0-0035958019
25. Cominacini L., Pasini A. F., Garbin U., Davoli A., Tosetti M. L., Campagnola M., Rigoni A., Pastorino A. M., Lo Cascio V., Sawamura T., Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF- B through an increased production of intracellular reactive oxygen species. The Journal of Biological Chemistry 2000 275 17 12633 12638 2-s2.0-0034724687 10.1074/jbc.275.17.12633 (Pubitemid 30241412)
26. Thum T., Borlak J., Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury: therapy through LOX-1 receptor antagonism? Circulation Research 2004 94 1 e1 e13 2-s2.0-17544385961
27. Chen X. P., Du G. H., Lectin-like oxidized low-density lipoprotein receptor-1: protein, ligands, expression and pathophysiological significance. Chinese Medical Journal 2007 120 5 421 426 2-s2.0-33947630915
28. Chen M., Nagase M., Fujita T., Narumiya S., Masaki T., Sawamura T., Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1 ligand and AGE. Biochemical and Biophysical Research Communications 2001 287 4 962 968 2-s2.0-0035812691 10.1006/bbrc.2001.5674 (Pubitemid 32953570)
29. Song G., Tian H., Liu J., Zhang H., Sun X., Qin S., H2 inhibits TNF- α -induced lectin-like oxidized LDL receptor-1 expression by inhibiting nuclear factor B activation in endothelial cells. Biotechnology Letters 2011 33 9 1715 1722 2-s2.0-80051470238 10.1007/s10529-011-0630-8
30. Hashizume M., Mihara M., Atherogenic effects of TNF- α and IL-6 via up-regulation of scavenger receptors. Cytokine 2012 58 3 424 430 2-s2.0-84860331375 10.1016/j.cyto.2012.02.010
31. Mukai E., Kume N., Hayashida K., Minami M., Yamada Y., Seino Y., Kita T., Heparin-binding EGF-like growth factor induces expression of lectin-like oxidized LDL receptor-1 in vascular smooth muscle cells. Atherosclerosis 2004 176 2 289 296 2-s2.0-5644251836 10.1016/j.atherosclerosis.2004.03.028 (Pubitemid 39369518)
32. Aoyama T., Fujiwara H., Masaki T., Sawamura T., Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. Journal of Molecular and Cellular Cardiology 1999 31 12 2101 2114 2-s2.0-0033378304 10.1006/jmcc.1999.1041 (Pubitemid 30029022)
33. Murase T., Kume N., Korenaga R., Ando J., Sawamura T., Masaki T., Kita T., Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circulation Research 1998 83 3 328 333 2-s2.0-0032504760 (Pubitemid 28371323)
34. Aramaki Y., Mitsuoka H., Toyohara M., Jinnai T., Kanatani K., Nakajima K., Mukai E., Yamada Y., Kita T., Inagaki N., Kume N., Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells. Atherosclerosis 2008 198 2 272 279 2-s2.0-43949103422 10.1016/j.atherosclerosis. 2007.12.017
35. Li D. Y., Zhang Y. C., Philips M. I., Sawamura T., Mehta J. L., Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circulation Research 1999 84 9 1043 1049 2-s2.0-0033553395 (Pubitemid 29227683)
36. Li L., Sawamura T., Renier G., Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium. Diabetes 2003 52 7 1843 1850 2-s2.0-0038353572 (Pubitemid 36792477)
37. Nagase M., Abe J., Takahashi K., Ando J., Hirose S., Fujita T., Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene. The Journal of Biological Chemistry 1998 273 50 33702 33707 2-s2.0-0032509552 10.1074/jbc.273.50.33702 (Pubitemid 29005759)
38. Nagase M., Hirose S., Sawamura T., Masaki T., Fujita T., Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochemical and Biophysical Research Communications 1997 237 3 496 498 2-s2.0-0031589565 10.1006/bbrc.1997.7176 (Pubitemid 27434712)
39. Nakano A., Inoue N., Sato Y., Nishimichi N., Takikawa K., Fujita Y., Kakino A., Otsui K., Yamaguchi S., Matsuda H., Sawamura T., LOX-1 mediates vascular lipid retention under hypertensive state. Journal of Hypertension 2010 28 6 1273 1280 2-s2.0-77952502169 10.1097/HJH.0b013e32833835d4
40. Kuge Y., Kume N., Ishino S., Takai N., Ogawa Y., Mukai T., Minami M., Shiomi M., Saji H., Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits. Biological and Pharmaceutical Bulletin 2008 31 8 1475 1482 2-s2.0-48849090195 10.1248/bpb.31.1475
41. Kataoka K., Hasegawa K., Sawamura T., Fujita M., Yanazume T., Iwai-Kanai E., Kawamura T., Hirai T., Kita T., Nohara R., LOX-1 pathway affects the extent of myocardial ischemia-reperfusion injury. Biochemical and Biophysical Research Communications 2003 300 3 656 660 2-s2.0-0037449921 10.1016/S0006-291X(02)02905- 4 (Pubitemid 36268886)
42. Kosaka H., Yoneyama H., Zhang L., Fujii S., Yamamoto A., Igarashi J., Induction of LOX-1 and iNOS expressions by ischemia-reperfusion of rat kidney and the opposing effect of L-arginine. The FASEB Journal 2003 17 6 636 643 2-s2.0-0037390850 10.1096/fj.02-0585com (Pubitemid 37221148)
43. Li D., Williams V., Liu L., Chen H., Sawamura T., Antakli T., Mehta J. L., LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation. The American Journal of Physiology-Heart and Circulatory Physiology 2002 283 5 H1795 H1801 2-s2.0-0036839541 (Pubitemid 35217012)
44. Li D., Williams V., Liu L., Chen H., Sawamura T., Romeo F., Mehta J. L., Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. Journal of the American College of Cardiology 2003 41 6 1048 1055 2-s2.0-0037454162 10.1016/S0735-1097(02)02966-2 (Pubitemid 36315552)
45. Hofnagel O., Luechtenborg B., Eschert H., Weissen-Plenz G., Severs N. J., Robenek H., Pravastatin Inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in Watanabe heritable hyperlipidemic rabbits: a new pleiotropic effect of statins. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 3 604 610 2-s2.0-33646549948 10.1161/01.ATV.0000201073.45862.8b
46. Mehta J. L., Hu B., Chen J., Li D., Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 12 2203 2208 2-s2.0-0346122777 10.1161/01.ATV.0000094411.98127. 5F (Pubitemid 37532321)
47. Mehta J. L., Chen J., Yu F., Li D. Y., Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells. Cardiovascular Research 2004 64 2 243 249 2-s2.0-5444220014 10.1016/j.cardiores. 2004.07.002 (Pubitemid 39361685)
48. Qiu Y., Tanaka T., Nawata H., Yanase T., Dihydrotestosterone inhibits lectin-like oxidized-LDL receptor-1 expression in aortic endothelial cells via a NF- B/AP-1-mediated mechanism. Endocrinology 2012 153 7 3405 3415 2-s2.0-84862744873 10.1210/en.2011-1993
49. Moriwaki H., Kume N., Sawamura T., Aoyama T., Hoshikawa H., Ochi H., Nishi E., Masaki T., Kita T., Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arteriosclerosis, Thrombosis, and Vascular Biology 1998 18 10 1541 1547 2-s2.0-0031667630 (Pubitemid 28465404)
50. Murphy J. E., Tacon D., Tedbury P. R., Hadden J. M., Knowling S., Sawamura T., Peckham M., Phillips S. E. V., Walker J. H., Ponnambalam S., LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells. Biochemical Journal 2006 393 1 107 115 2-s2.0-30044443918 10.1042/BJ20051166 (Pubitemid 43049307)
51. Oka K., Sawamura T., Kikuta K., Itokawa S., Kume N., Kita T., Masaki T., Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 1998 95 16 9535 9540 2-s2.0-0032482958 10.1073/pnas.95.16.9535 (Pubitemid 28506266)
52. Kakutani M., Masaki T., Sawamura T., A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1. Proceedings of the National Academy of Sciences of the United States of America 2000 97 1 360 364 2-s2.0-0034602694 (Pubitemid 30055836)
53. Jono T., Miyazaki A., Nagai R., Sawamura T., Kitamura T., Horiuchi S., Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Letters 2002 511 1-3 170 174 2-s2.0-0037196444 10.1016/S0014-5793(01)03325-7 (Pubitemid 34127844)
54. Shimaoka T., Kume N., Minami M., Hayashida K., Sawamura T., Kita T., Yonehara S., LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria. Journal of Immunology 2001 166 8 5108 5114 2-s2.0-0035871712 (Pubitemid 32280724)
55. Yamanaka S., Zhang X. Y., Miura K., Kim S., Iwao H., The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile. Genomics 1998 54 2 191 199 2-s2.0-0032403484 10.1006/geno.1998.5561 (Pubitemid 28553628)
56. Navarra T., Del Turco S., Berti S., Basta G., The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications. Journal of Atherosclerosis and Thrombosis 2010 17 4 317 331 2-s2.0-77953531592
57. Tan K. C., Shiu S. W. M., Wong Y., Leng L., Bucala R., Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus. Journal of Lipid Research 2008 49 7 1438 1444 2-s2.0-50949106121 10.1194/jlr.M700551-JLR200
58. Kataoka H., Kume N., Miyamoto S., Minami M., Murase T., Sawamura T., Masaki T., Hashimoto N., Kita T., Biosynthesis and post-translational processing of lectin-like oxidized low density lipoprotein receptor-1 (LOX-1). N-linked glycosylation affects cell-surface expression and ligand binding. The Journal of Biological Chemistry 2000 275 9 6573 6579 2-s2.0-0034054502 10.1074/jbc.275.9.6573 (Pubitemid 30129958)
59. Hermonat P. L., Zhu H., Cao M., Mehta J. L., LOX-1 transcription. Cardiovascular Drugs and Therapy 2011 25 5 393 400 2-s2.0-83055188288 10.1007/s10557-011-6322-8
60. Mango R., Clementi F., Borgiani P., Forleo G. B., Federici M., Contino G., Giardina E., Garza L., Fahdi I. E., Lauro R., Mehta J. L., Novelli G., Romeo F., Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. Journal of Medical Genetics 2003 40 12 933 936 2-s2.0-9144244821 (Pubitemid 38117545)
61. Ohmori R., Momiyama Y., Nagano M., Taniguchi H., Egashira T., Yonemura A., Nakamura H., Kondo K., Ohsuzu F., An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease. Clinical Cardiology 2004 27 11 641 644 2-s2.0-7444258994 (Pubitemid 39441747)
62. Chen M., Inoue K., Narumiya S., Masaki T., Sawamura T., Requirements of basic amino acid residues within the lectin-like domain of LOX-1 for the binding of oxidized low-density lipoprotein. FEBS Letters 2001 499 3 215 219 2-s2.0-0035933585 10.1016/S0014-5793(01)02557-1 (Pubitemid 32553867)
63. Biocca S., Falconi M., Filesi I., Baldini F., Vecchione L., Mango R., Romeo F., Federici G., Desideri A., Novelli G., Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity. PLoS One 2009 4 2 e4648
64. Mango R., Biocca S., del Vecchio F., Clementi F., Sangiuolo F., Amati F., Filareto A., Grelli S., Spitalieri P., Filesi I., Favalli C., Lauro R., Mehta J. L., Romeo F., Novelli G., In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circulation Research 2005 97 2 152 158 2-s2.0-22744450055 10.1161/01.RES. 0000174563.62625.8e (Pubitemid 41033471)
65. Biocca S., Filesi I., Mango R., Maggiore L., Baldini F., Vecchione L., Viola A., Citro G., Federici G., Romeo F., Novelli G., The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization. Journal of Molecular and Cellular Cardiology 2008 44 3 561 570 2-s2.0-40649099556 10.1016/j.yjmcc.2007.11.017
66. Sakamoto N., Ishibashi T., Sugimoto K., Sawamura T., Sakamoto T., Inoue N., Saitoh S., Kamioka M., Uekita H., Ohkawara H., Suzuki K., Teramoto T., Maruyama Y., Takeishi Y., Role of LOX-1 in monocyte adhesion-triggered redox, Akt/eNOS and Ca 2+ signaling pathways in endothelial cells. Journal of Cellular Physiology 2009 220 3 706 715 2-s2.0-67650360011 10.1002/jcp.21818
67. Quehenberger O., Thematic review series: the immune system and atherogenesis. Molecular mechanisms regulating monocyte recruitment in atherosclerosis. Journal of Lipid Research 2005 46 8 1582 1590 2-s2.0-23244461849 10.1194/jlr.R500008-JLR200 (Pubitemid 41099324)
68. Goyal T., Mitra S., Khaidakov M., Wang X., Singla S., Ding Z., Liu S., Mehta J. L., Current concepts of the role of oxidized LDL receptors in atherosclerosis. Current Atherosclerosis Reports 2012 14 2 150 159 2-s2.0-84862776951 10.1007/s11883-012-0228-1
69. Li D., Liu L., Chen H., Sawamura T., Ranganathan S., Mehta J. L., LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation 2003 107 4 612 617 2-s2.0-0037418043 10.1161/01.CIR.0000047276.52039.FB (Pubitemid 36176813)
70. Sugimoto K., Ishibashi T., Sawamura T., Inoue N., Kamioka M., Uekita H., Ohkawara H., Sakamoto T., Sakamoto N., Okamoto Y., Takuwa Y., Kakino A., Fujita Y., Tanaka T., Teramoto T., Maruyama Y., Takeishi Y., LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells. Cardiovascular Research 2009 84 1 127 136 2-s2.0-70449706057 10.1093/cvr/cvp177
71. Myatt L., Placental adaptive responses and fetal programming. Journal of Physiology 2006 572 1 25 30 2-s2.0-33645306841 10.1113/jphysiol.2006.104968
72. Di Cianni G., Miccoli R., Volpe L., Lencioni C., Del Prato S., Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes/Metabolism Research and Reviews 2003 19 4 259 270 2-s2.0-0042093521 10.1002/dmrr.390 (Pubitemid 36939851)
73. Ethier-Chiasson M., Forest J. C., Giguère Y., Masse A., Marseille-Tremblay C., Lévy E., Lafond J., Modulation of placental protein expression of OLR1: implication in pregnancy-related disorders or pathologies. Reproduction 2008 136 4 491 502 2-s2.0-55049088579 10.1530/REP-08-0082
74. Pavan L., Hermouet A., Tsatsaris V., Thérond P., Sawamura T., Evain-Brion D., Fournier T., Lipids from oxidized low-density lipoprotein modulate human trophoblast invasion: involvement of nuclear liver X receptors. Endocrinology 2004 145 10 4583 4591 2-s2.0-4644245073 10.1210/en.2003-1747 (Pubitemid 39281451)
75. Fournier T., Handschuh K., Tsatsaris V., Guibourdenche J., Evain-Brion D., Role of nuclear receptors and their ligands in human trophoblast invasion. Journal of Reproductive Immunology 2008 77 2 161 170 2-s2.0-40449135786 10.1016/j.jri.2007.05.004 (Pubitemid 351343827)
76. Lee H., Park H., Kim Y. J., Kim H. J., Ahn Y. M., Park B., Park J. H., Eun Lee B., Expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in human preeclamptic placenta: possible implications in the process of trophoblast apoptosis. Placenta 2005 26 2-3 226 233 2-s2.0-13844254052 10.1016/j.placenta.2004.05.012 (Pubitemid 40247011)
77. Chigusa Y., Tatsumi K., Kondoh E., Fujita K., Nishimura F., Mogami H., Konishi I., Decreased lectin-like oxidized LDL receptor 1 (LOX-1) and low Nrf2 activation in placenta are involved in preeclampsia. Journal of Clinical Endocrinology and Metabolism 2012 97 10 E1862 E1870 2-s2.0-84867280729 10.1210/jc.2012-1268
78. Satoh H., Kiyota E., Terasaki Y., Sawamura T., Takagi K., Mizuta H., Takeya M., Expression and localization of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in murine and human placentas. Journal of Histochemistry and Cytochemistry 2008 56 8 773 784 2-s2.0-47249089663 10.1369/jhc.2008.950543 (Pubitemid 351991090)
79. Fournier T., Handschuh K., Tsatsaris V., Evain-Brion D., Involvement of PPAR γ in human trophoblast invasion. Placenta A 2007 28 S76 S81 2-s2.0-34047134454 10.1016/j.placenta.2006.12.006 (Pubitemid 46508698)
80. Mehta J. L., Sanada N., Hu C. P., Chen J., Dandapat A., Sugawara F., Satoh H., Inoue K., Kawase Y., Jishage K., Suzuki H., Takeya M., Schnackenberg L., Beger R., Hermonat P. L., Thomas M., Sawamura T., Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circulation Research 2007 100 11 1634 1642 2-s2.0-34250190986 10.1161/CIRCRESAHA.107.149724 (Pubitemid 46897266)
81. Duley L., The global impact of Pre-eclampsia and eclampsia. Seminars in Perinatology 2009 33 3 130 137 2-s2.0-65649125690 10.1053/j.semperi.2009.02.010
82. Xiong X., Demianczuk N. N., Saunders L. D., Wang F. L., Fraser W. D., Impact of preeclampsia and gestational hypertension on birth weight by gestational age. The American Journal of Epidemiology 2002 155 3 203 209 2-s2.0-0036468513 10.1093/aje/155.3.203 (Pubitemid 34117298)
83. Escudero C., Sobrevia L., A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta 2008 29 6 469 483 2-s2.0-44149093091 10.1016/j.placenta.2008.02.008
84. Villar J., Carroli G., Wojdyla D., Abalos E., Giordano D., Ba'aqeel H., Farnot U., Bergsjø P., Bakketeig L., Lumbiganon P., Campodónico L., Al-Mazrou Y., Lindheimer M., Kramer M., Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? The American Journal of Obstetrics and Gynecology 2006 194 4 921 931 2-s2.0-33645884129 10.1016/j.ajog.2005.10.813
85. Sibai B., Dekker G., Kupferminc M., Pre-eclampsia. The Lancet 2005 365 9461 785 799 2-s2.0-14644412849 10.1016/S0140-6736(05)17987-2 (Pubitemid 40311367)
86. Cunningham F. G., Lindheimer M. D., Current concepts: hypertension in pregnancy. The New England Journal of Medicine 1992 326 14 927 932 2-s2.0-0027108635
87. Carr D. B., McDonald G. B., Brateng D., Desai M., Thach C. T., Easterling T. R., The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia. Obstetrics and Gynecology 2001 98 6 1109 1116 2-s2.0-0035693703 10.1016/S0029-7844(01)01574-5 (Pubitemid 34075339)
88. Ahmad S., Ahmed A., Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circulation Research 2004 95 9 884 891 2-s2.0-7244238090 10.1161/01.RES.0000147365.86159.f5 (Pubitemid 39435003)
89. Brown M. A., Lindheimer M. D., de Swiet M., Van Assche A., Moutquin J. M., The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy (ISSHP). Hypertension in Pregnancy 2001 20 1 9 14 2-s2.0-0034916930 10.1081/PRG-100104165 (Pubitemid 32672922)
90. American College of Obstetricians Gynecologists, Hypertension in pregnancy. 2013, http://www.acog.org/Resources-And-Publications/Task-Force-and- Work-Group-Reports/Hypertension-in-Pregnancy
91. Mattar F., Sibai B. M., Eclampsia. VIII. Risk factors for maternal morbidity. The American Journal of Obstetrics and Gynecology 2000 182 2 307 312 2-s2.0-0038387601 (Pubitemid 30127340)
92. Keiser S. D., Boyd K. W., Rehberg J. F., Elkins S., Owens M. Y., Sunesara I., Martin J. N. Jr., A high LDH to AST ratio helps to differentiate pregnancy-associated thrombotic thrombocytopenic purpura (TTP) from HELLP syndrome. Journal of Maternal-Fetal and Neonatal Medicine 2012 25 7 1059 1063 2-s2.0-84862902108 10.3109/14767058.2011.619603
93. Homer C. S., Brown M. A., Mangos G., Davis G. K., Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. Journal of Hypertension 2008 26 2 295 302 2-s2.0-38149129510 10.1097/HJH.0b013e3282f1a953
94. Raijmakers M. T., Dechend R., Poston L., Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension 2004 44 4 374 380 2-s2.0-4644311708 10.1161/01.HYP.0000141085.98320.01 (Pubitemid 39281478)
95. Rosser M. L., Katz N. T., Preeclampsia: an obstetrician's perspective. Advances in Chronic Kidney Disease 2013 20 3 287 296 2-s2.0-84876878279 10.1053/j.ackd.2013.02.005
96. Khan K. S., Wojdyla D., Say L., Gülmezoglu A. M., van Look P. F., WHO analysis of causes of maternal death: a systematic review. The Lancet 2006 367 9516 1066 1074 2-s2.0-33645737208 10.1016/S0140-6736(06)68397-9
97. Sandvik M. K., Leirgul E., Nygård O., Ueland P. M., Berg A., Svarstad E., Vikse B. E., Preeclampsia in healthy women and endothelial dysfunction 10 years later. The American Journal of Obstetrics and Gynecology 2013 209 6 569.e1 569.e10 2-s2.0-84882558762 10.1016/j.ajog.2013.07.024
98. Szpera-Gozdziewicz A., Breborowicz G. H., Endothelial dysfunction in the pathogenesis of pre-eclampsia. Frontiers in Bioscience 2014 19 734 746 10.2741/4240
99. Henriques A. C., Carvalho F. H., Feitosa H. N., Macena R. H., Mota R. M., Alencar J. C., Endothelial dysfunction after pregnancy-induced hypertension. International Journal of Gynecology & Obstetrics 2014 124 3 230 234 10.1016/j.ijgo.2013.08.016
100. Roberts J. M., Escudero C., The placenta in preeclampsia. Pregnancy Hypertension 2012 2 2 72 83 2-s2.0-84859158869 10.1016/j.preghy.2012.01.001
101. Redman C. W. G., Pre-eclampsia and the placenta. Placenta 1991 12 4 301 308 2-s2.0-0026198207
102. Piering W. F., Garancis J. G., Becker C. G., Beres J. A., Lemann J. Jr., Preeclampsia related to a functioning extrauterine placenta report of a case and 25-year follow-up. The American Journal of Kidney Diseases 1993 21 3 310 313 2-s2.0-0027538010 (Pubitemid 23100345)
103. Chun D., Braga C., Chow C., Lok L., Clinical observations on some aspects of hydatidiform moles. The Journal of obstetrics and gynaecology of the British Commonwealth 1964 71 180 184 2-s2.0-0001616956
104. Cockell A. P., Learmont J. G., Smarason A. K., Redman C. W., Sargent I. L., Poston L., Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. The British Journal of Obstetrics and Gynaecology 1997 104 2 235 240 2-s2.0-0031057140 (Pubitemid 27065151)
105. Redman C. W., Sargent I. L., Placental debris, oxidative stress and pre-eclampsia. Placenta 2000 21 7 597 602 2-s2.0-0033832416 10.1053/plac.2000. 0560
106. Roberts J. M., Preeclampsia: is there value in assessing before clinically evident disease? Obstetrics and Gynecology 2001 98 4 596 599 2-s2.0-0034802853 10.1016/S0029-7844(01)01594-0 (Pubitemid 32907453)
107. Redman C. W., Sargent I. L., Latest advances in understanding preeclampsia. Science 2005 308 5728 1592 1594 2-s2.0-20444409135 10.1126/science.1111726 (Pubitemid 40807500)
108. Goswamia D., Tannetta D. S., Magee L. A., Fuchisawa A., Redman C. W., Sargent I. L., von Dadelszen P., Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 2006 27 1 56 61 2-s2.0-27944467137 10.1016/j.placenta.2004.11.007 (Pubitemid 41662880)
109. Roberts D. J., Post M. D., The placenta in pre-eclampsia and intrauterine growth restriction. Journal of Clinical Pathology 2008 61 12 1254 1260 2-s2.0-57549083868 10.1136/jcp.2008.055236
110. Roberts J. M., Preeclampsia: new approaches but the same old problems. The American Journal of Obstetrics and Gynecology 2008 199 5 443 444 2-s2.0-54849412992 10.1016/j.ajog.2008.07.005
111. Levine R. J., Maynard S. E., Qian C., Lim K. H., England L. J., Yu K. F., Schisterman E. F., Thadhani R., Sachs B. P., Epstein F. H., Sibai B. M., Sukhatme V. P., Karumanchi S. A., Circulating angiogenic factors and the risk of preeclampsia. The New England Journal of Medicine 2004 350 7 672 683 2-s2.0-10744227199 10.1056/NEJMoa031884 (Pubitemid 38364626)
112. Gregory A. L., Xu G., Sotov V., Letarte M., Review: the enigmatic role of endoglin in the placenta. Placenta 2014 35 supplement S93 S99 10.1016/j.placenta.2013.10.020
113. Atamer Y., Koçyigit Y., Yokus B., Atamer A., Erden A. C., Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia. European Journal of Obstetrics Gynecology and Reproductive Biology 2005 119 1 60 66 2-s2.0-14244263052 10.1016/j.ejogrb.2004.06.033 (Pubitemid 40289099)
114. Davison J. M., Homuth V., Jeyabalan A., Conrad K. P., Karumanchi S. A., Quaggin S., Dechend R., Luft F. C., New aspects in the pathophysiology of preeclampsia. Journal of the American Society of Nephrology 2004 15 9 2440 2448 2-s2.0-4344629059 10.1097/01.ASN.0000135975.90889.60 (Pubitemid 39159344)
115. Beker J. C., Etiology of puerperal eclampsia. Nederlandsch Tijdschrift voor Verloskunde en Gynaecologie 1950 50 2 99 107 2-s2.0-77049335316
116. Tadesse S., Kidane D., Guller S., Luo T., Norwitz N. G., Arcuri F., Toti P., Norwitz E. R., In vivo and in vitro evidence for placental DNA damage in preeclampsia. PLoS One 2014 9 e86791 10.1371/journal.pone.0086791
117. Pimentel A. M., Pereira N. R., Costa C. A., Mann G. E., Cordeiro V. S., de Moura R. S., Brunini T. M., Mendes-Ribeiro A. C., Resende A. C., L-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia. Hypertension Research 2013 36 783 788 10.1038/hr.2013.34
118. Raijmakers M. T., Burton G. J., Jauniaux E., Seed P. T., Peters W. H., Steegers E. A., Poston L., Placental NAD(P)H oxidase mediated superoxide generation in early pregnancy. Placenta 2006 27 2-3 158 163 2-s2.0-28844473251 10.1016/j.placenta.2005.02.013 (Pubitemid 41763457)
119. Casanueva E., Viteri F. E., Iron and oxidative stress in pregnancy. Journal of Nutrition 2003 133 5, supplement 2 1700S 1708S 2-s2.0-0037547073 (Pubitemid 36548678)
120. Klingler M., Demmelmair H., Larque E., Koletzko B., Analysis of FA contents in individual lipid fractions from human placental tissue. Lipids 2003 38 5 561 566 2-s2.0-0038269255 10.1007/s11745-003-1496-8 (Pubitemid 36760245)
121. Mihailović M., Cvetković M., Ljubić A., Kosanović M., Nedeljković S., Jovanović I., Pešut O., Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid. Biological Trace Element Research 2000 73 1 47 54 2-s2.0-0033956479 (Pubitemid 30101941)
122. Arikan S., Konukolu D., Arikan Ç., Akçay T., Davas I., Lipid peroxidation and antioxidant status in maternal and cord blood. Gynecologic and Obstetric Investigation 2001 51 3 145 149 2-s2.0-0035049195 10.1159/000052913 (Pubitemid 32304733)
123. Mueller A., Koebnick C., Binder H., Hoffmann I., Schild R. L., Beckmann M. W., Dittrich R., Placental defence is considered sufficient to control lipid peroxidation in pregnancy. Medical Hypotheses 2005 64 3 553 557 2-s2.0-11144304549 10.1016/j.mehy.2004.08.008 (Pubitemid 40023018)
124. Burdon C., Mann C., Cindrova-Davies T., Ferguson-Smith A. C., Burton G. J., Oxidative stress and the induction of cyclooxygenase enzymes and apoptosis in the murine placenta. Placenta 2007 28 7 724 733 2-s2.0-34249775172 10.1016/j.placenta.2006.12.001 (Pubitemid 46852300)
125. Gupta S., Agarwal A., Sharma R. K., The role of placental oxidative
126. Walsh S. W., Vaughan J. E., Wang Y., Roberts L. J. II, Placental isoprostane is significantly increased in preeclampsia. The FASEB Journal 2000 14 10 1289 1296 2-s2.0-0033934769 (Pubitemid 30439737)
127. Noris M., Todeschini M., Cassis P., Pasta F., Cappellini A., Bonazzola S., Macconi D., Maucci R., Porrati F., Benigni A., Picciolo C., Remuzzi G., L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 2004 43 3 614 622 2-s2.0-10744232765 10.1161/01.HYP.0000116220.39793.c9 (Pubitemid 38282437)
128. Wang Y., Walsh S. W., Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. Journal of the Society for Gynecologic Investigation 1996 3 4 179 184 2-s2.0-0030200307 10.1016/1071-5576(96)00015-9 (Pubitemid 26242202)
129. Vanderlelie J., Venardos K., Clifton V. L., Gude N. M., Clarke F. M., Perkins A. V., Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 2005 26 1 53 58 2-s2.0-12344299190 10.1016/j.placenta.2004.04.002 (Pubitemid 40123676)
130. Kharb S., Low whole blood glutathione levels in pregnancies complicated by preeclampsia and diabetes. Clinica Chimica Acta 2000 294 1-2 179 183 2-s2.0-0034113389 10.1016/S0009-8981(99)00253-3 (Pubitemid 30155817)
131. Chen G., Wilson R., Cumming G., Walker J. J., Smith W. E., McKillop J. H., Intracellular and extracellular antioxidant buffering levels in erythrocytes from pregnancy-induced hypertension. Journal of Human Hypertension 1994 8 1 37 42 2-s2.0-0027953476 (Pubitemid 24052186)
132. Kharb S., Vitamin E and C in preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 2000 93 1 37 39 10.1016/S0301- 2115(00)00243-8
133. Ghio A., Bertolotto A., Resi V., Volpe L., Di Cianni G., Triglyceride metabolism in pregnancy. Advances in Clinical Chemistry 2011 55 133 153 2-s2.0-80052653688 10.1016/B978-0-12-387042-1.00007-1
134. Leiva A., de Medina C. D., Salsoso R., Sáez T., San Martín S., Abarzúa F., Farías M., Guzmán-Gutiérrez E., Pardo F., Sobrevia L., Maternal hypercholesterolemia in pregnancy associates with umbilical vein endothelial dysfunction: role of endothelial nitric oxide synthase and arginase II. Arteriosclerosis, Thrombosis, and Vascular Biology 2013 33 2444 2453 2-s2.0-84881346588 10.1161/ATVBAHA.113.301987
135. Sankaralingam S., Xu Y., Sawamura T., Davidge S. T., Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia role for peroxynitrite. Hypertension 2009 53 2 270 277 2-s2.0-59849094468 10.1161/HYPERTENSIONAHA.108. 122630
136. Cummings S. W., Hatley W., Simpson E. R., Ohashi M., The binding of high and low density lipoproteins to human placental membrane fractions. Journal of Clinical Endocrinology and Metabolism 1982 54 5 903 908 2-s2.0-0020402097 (Pubitemid 13243696)
137. Gåfvels M. E., Coukos G., Sayegh R., Coutifaris C., Strickland D. K., Strauss J. F. III, Regulated expression of the trophoblast α 2-macroglobulin receptor/low density lipoprotein receptor-related protein: Differentiation and cAMP modulate protein and mRNA levels. The Journal of Biological Chemistry 1992 267 29 21230 21234 2-s2.0-0026701852
138. Wittmaack F. M., Gåfvels M. E., Bronner M., Matsuo H., Mccrae K. R., Tomaszewski J. E., Robinson S. L., Strickland D. K., Strauss J. F. III, Localization and regulation of the human very low density lipoprotein/ apolipoprotein-E receptor: trophoblast expression predicts a role for the receptor in placental lipid transport. Endocrinology 1995 136 1 340 348 2-s2.0-0028861257 10.1210/en.136.1.340
139. Bonet B., Chait A., Gown A. M., Knopp R. H., Metabolism of modified LDL by cultured human placental cells. Atherosclerosis 1995 112 2 125 136 2-s2.0-0028931906 10.1016/0021-9150(94)05404-7
140. Cao G., Garcia C. K., Wyne K. L., Schultz R. A., Parker K. L., Hobbs H. H., Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1. The Journal of Biological Chemistry 1997 272 52 33068 33076 2-s2.0-0031453246 10.1074/jbc.272.52.33068 (Pubitemid 28023648)
141. Lafond J., Charest M.-C., Alain J. F., Brissette L., Masse A., Robidoux J., Simoneau L., Presence of CLA-1 and HDL binding sites on syncytiotrophoblast brush border and basal plasma membranes of human placenta. Placenta 1999 20 7 583 590 2-s2.0-0032814306 10.1053/plac.1999.0412 (Pubitemid 29391303)
142. Yoshida H., Kondratenko N., Green S., Steinberg D., Quehenberger O., Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochemical Journal 1998 334 part 1 9 13 2-s2.0-0032528913 (Pubitemid 28420964)
143. Morton J. S., Abdalvand A., Jiang Y., Sawamura T., Uwiera R. R. E., Davidge S. T., Lectin-like oxidized low-density lipoprotein 1 receptor in a reduced uteroplacental perfusion pressure rat model of preeclampsia. Hypertension 2012 59 5 1014 1020 2-s2.0-84862819937 10.1161/HYPERTENSIONAHA.112. 191825
144. English F. A., McCarthy F. P., McSweeney C. L., Quon A. L., Morton J. S., Sawamura T., Davidge S. T., Kenny L. C., Inhibition of lectin-like oxidized low-density lipoprotein-1 receptor protects against plasma-mediated vascular dysfunction associated with pre-eclampsia. The American Journal of Hypertension 2013 26 2 279 286 2-s2.0-84876561566 10.1093/ajh/hps035
145. Schreurs M. P. H., Hubel C. A., Bernstein I. M., Jeyabalan A., Cipolla M. J., Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1. The FASEB Journal 2013 27 3 1254 1263 2-s2.0-84874596863 10.1096/fj.12-222216
146. Jiang D. Q., Chu L. X., Liu Z. Y., Zhang S. B., Pioglitazone decreased CD40/CD40L expression on human umbilical vein endothelial cells induced by oxidized low-density lipoprotein. Clinica Chimica Acta 2006 370 1-2 94 99 2-s2.0-33746102184 10.1016/j.cca.2006.01.026 (Pubitemid 44080172)
147. Li D., Liu L., Chen H., Sawamura T., Mehta J. L., LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 5 816 821 2-s2.0-0038301121 10.1161/01.ATV.0000066685.13434.FA (Pubitemid 36566171)